Zimmer Biomet Spine Announces Multiple Podium Presentations and Company Highlights at NASS

Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, today announced multiple oral and poster presentations and key company highlights at the North American Spine Society (NASS) 2018 Annual Meeting, being held this week in Los Angeles, Calif. The company is showcasing multiple solutions from its Spine portfolio, including, Mobi-C Cervical Disc, ProLift Expandable Spacer System, and Cypher MIS Screw System, as well as its Surgery Assisting Technology (SAT) Platform, which was unveiled earlier this year, including the WalterLorenz Surgical Assist Arm, a bionic, electromechanical arm designed to enable accurate and effective retraction and instrument positioning during surgery, reducing staff fatigue, and helping improve efficiency in the operating room.
 
The Mobi-C Cervical Disc is the leading option for cervical total disc replacement designed to restore a healthy disc height and maintain patient range of motion at the operated level. Long-term outcomes of Mobi-C will be presented in two podium presentations and a poster during the meeting.
 
Additionally, Zimmer Biomet Spine will feature the ProLift Expandable Spacer System and Cypher MIS Screw System. The ProLift expandable interbody system with Osseo-LOC surface technology provides a minimally-invasive solution for TLIF and PLIF procedures with in-situ expansion for restoration of normal anatomic disc height and decompression of neural elements. Streamlined instrumentation aims to provide the surgeon minimal tissue disruption and nerve retraction while achieving surgical goals and restoring patient alignment. Cypher is an MIS screw system designed to make it easier to introduce rods, reduce the amount of rod manipulation during surgery placement, and encourage optimal screw placement.
 
Zimmer Biomet’s Surgery Assisting Technology (SAT) is a platform of collaborative technologies and services that help surgeons and staff streamline the delivery of care, including diagnostics, pre-operative planning, intraoperative procedures, post-operative care, and health outcomes.
 
Rebecca Whitney, general manager of Global Spine, commented, “With key podium presentations on the longest-term outcomes to date, out to 10 years, for our cervical total disc replacement solution Mobi-C, multiple company presentation sessions, and a concentration on demonstrating the differentiators of our Spine and Surgery Assisting Technology portfolio options, we anticipate that this year’s NASS meeting will prove to be an extremely engaging and productive opportunity for Zimmer Biomet to connect with spine surgeons. Our recently-launched SAT platform represents the company’s commitment to the highest standards of patient safety and quality in our products and services. SAT enables streamlined care delivery, improved patient experience, and enhanced health outcomes. We look forward to sharing details on this cross-functionality and our unique offerings with the spine surgeon community.”
 
Details of the presentations include:
 
Oral Presentation:           Abstract #134. Ten-Year Radiographic Analysis of One- and Two-Level Cervical Disc Arthroplasty in a U.S. Multicenter Study
Session:                               Section on Motion Technology Abstract Presentations, moderated by: Lisa A. Ferrara, Ph.D.
Date:                               Sept. 27; 3:53 p.m. – 3:59 p.m.
Location:                              Room 406AB
Presenting Author:          Kee D. Kim, M.D.; UC Davis School of Medicine, Sacramento, Calif.
Product Focus:                  Mobi-C
 
Oral Presentation:           Abstract #137. How Do Patients With Predominant Chronic Neck Pain Experience Cervical Disc Replacement? Results from a Prospective Study at Five-Year Follow-Up
Session:                               Section on Motion Technology Abstract Presentations, moderated by: Lisa A. Ferrara, Ph.D.
Date:                               Sept. 27; 4:26 p.m. – 4:32 p.m.
Location:                              Room 406AB
Presenting Author:          Jacques Beaurain, M.D.; Neurochirurgie CHU Hôpital Général, Dijon, France
Product Focus:                  Mobi-C
 
ePoster:                               P115. Clinical Adjacent Segment Pathology Following Treatment with CDA or ACDF at One or Two-Levels Through Seven Years
Presenting Author:          Pierce D. Nunley, M.D.; Spine Institute of Louisiana, Shreveport, La.
 
Zimmer Biomet is showcasing the Mobi-C, ProLift and Cypher Systems and the SAT Platform at booth No. 1713 in the Exhibit Hall.
 
Mobi-C is the first cervical disc prosthesis approved by the U.S. Food and Drug Administration for reconstruction of the cervical disc at both one and two levels to treat severe pain in the neck or arm caused by various spine disorders or injuries. Mobi-C is a cobalt chromium alloy and polyethylene mobile-bearing prosthesis that is inserted in a single step, without requiring bone chiseling to accommodate vertebral anchorage such as screws or keels. The Mobi-C Cervical Disc Prosthesis is indicated in skeletally mature patients for reconstruction of the disc from C3-C7 following discectomy at one level or two contiguous levels for intractable radiculopathy (arm pain and/or neurological deficit) with or without neck pain or myelopathy due to abnormality localized to the level of the disc space and at least one of the following conditions confirmed by radiographic imaging (CT, MRI or X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes) and/or visible loss of disc height compared to adjacent levels. The Mobi-C Cervical Disc Prosthesis is implanted using an anterior approach. Patients should have failed at least six weeks of conservative treatment or demonstrated progressive signs or symptoms despite nonoperative treatment prior to implantation of the Mobi-C Cervical Disc Prosthesis.
 
Founded in 1927 and headquartered in Warsaw, Ind., Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. The company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet has operations in more than 25 countries around the world and sells products in more than 100 countries.